Clearmind Medicine Inc (CMND)

Jul 20, 2025

Is Clearmind Medicine Inc. a good long term investmentExplosive earnings growth - jammulinksnews.com

Jul 20, 2025

Jul 20, 2025

How Clearmind Medicine Inc. stock reacts to Fed policy changesFree Access to Community with 300% Return - beatles.ru

Jul 20, 2025

Jul 20, 2025

What drives Clearmind Medicine Inc. stock priceExceptional gains - Autocar Professional

Jul 20, 2025

Jul 19, 2025

What analysts say about Clearmind Medicine Inc. stockUnstoppable profit momentum - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

Clearmind Medicine Inc. Stock Analysis and ForecastPhenomenal trading returns - jammulinksnews.com

Jul 18, 2025

Jul 16, 2025

What makes Clearmind Medicine Inc. stock price move sharplySmart Money Trade Setups - beatles.ru

Jul 16, 2025

Jul 16, 2025

Clearmind Expands its Clinical Trial for Alcohol Use, New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 16, 2025

Jul 15, 2025

How Clearmind Medicine Inc. stock performs during market volatilityFree High-Accuracy Stock Picks - Newser

Jul 15, 2025

Jul 15, 2025

Why Clearmind Medicine Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser

Jul 15, 2025

Jul 15, 2025

Clearmind Expands Its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 15, 2025

Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment By Investing.com - Investing.com South Africa

Jul 15, 2025

Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment - Investing.com India

Jul 15, 2025

Jul 15, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 to Johns Hopkins University to Address Alcohol Use Disorder - Nasdaq

Jul 15, 2025

Jul 15, 2025

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - The Manila Times

Jul 15, 2025

Jul 09, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Price Up 4.5% – Here’s Why - Defense World

Jul 09, 2025

Jul 09, 2025

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance

Jul 09, 2025

Jul 04, 2025

Clearmind Medicine Soars 32.89% on Clinical Trial Approval - AInvest

Jul 04, 2025

Jul 03, 2025

CMND’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 03, 2025

Jul 03, 2025

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial - Nasdaq

Jul 03, 2025

Jul 03, 2025

Clearmind’s Stock Gains Momentum with New Trial Expansions - timothysykes.com

Jul 03, 2025

Jul 03, 2025

Clearmind Medicine’s Rise: What’s Steering the Surge? - timothysykes.com

Jul 03, 2025

Jul 03, 2025

Clearmind receives IRB approval for alcohol disorder treatment trial - Investing.com

Jul 03, 2025

Jul 03, 2025

Clearmind receives IRB approval for alcohol disorder treatment trial By Investing.com - Investing.com South Africa

Jul 03, 2025

Jul 03, 2025

Clearmind Medicine Inc. Receives IRB Approval for Phase 1/2a Clinical Trial of CMND-100 for Alcohol Use Disorder - Nasdaq

Jul 03, 2025

Jun 30, 2025

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder - The Manila Times

Jun 30, 2025

Jun 30, 2025

Clearmind doses first participant in alcohol disorder treatment trial - Investing.com

Jun 30, 2025

Jun 30, 2025

Clearmind doses first participant in alcohol disorder treatment trial By Investing.com - Investing.com Canada

Jun 30, 2025

Jun 28, 2025

Clearmind Medicine's Global AUD Trial Expansion: Seizing the $775M Market's Psychedelic Opportunity - AInvest

Jun 28, 2025

Jun 27, 2025

Clearmind adds Hadassah Medical Center to alcohol disorder drug trial By Investing.com - Investing.com South Africa

Jun 27, 2025

Jun 27, 2025

Clearmind Adds New Site to Trial for Experimental Alcohol Use Disorder Drug - MarketScreener

Jun 27, 2025

Jun 25, 2025

Clearmind enrolls first patient in CMND-100 alcohol disorder trial - Investing.com India

Jun 25, 2025

Jun 25, 2025

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment - Yahoo Finance

Jun 25, 2025

Jun 24, 2025

Clearmind Medicine Inc. Engages Consulting Firm to Advance Psychedelic-Based Treatments and Regulatory Advocacy - Nasdaq

Jun 24, 2025

Jun 23, 2025

Clearmind adds Tel Aviv medical center to alcohol disorder drug trial - Investing.com India

Jun 23, 2025

Jun 23, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 with Tel Aviv Sourasky Medical Center Collaboration - Nasdaq

Jun 23, 2025

Jun 16, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jun 16, 2025

Jun 16, 2025

Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update - Defense World

Jun 16, 2025

Jun 13, 2025

Clearmind Medicine Retains Crescendo Communications LLC. for Investor Relations and Announces Granting of Stock and Warrants - Psychedelic Alpha

Jun 13, 2025

Jun 12, 2025

Clearmind Medicine Inc. (NASDAQ:CMND) Shares Acquired by Citadel Advisors LLC - Defense World

Jun 12, 2025

Jun 12, 2025

# Clearmind Medicine hires lobbying firm to advance psychedelic therapy By Investing.com - Investing.com South Africa

Jun 12, 2025

Jun 12, 2025

# Clearmind Medicine hires lobbying firm to advance psychedelic therapy - Investing.com Australia

Jun 12, 2025

Jun 12, 2025

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics - The Manila Times

Jun 12, 2025

Jun 12, 2025

Clearmind Medicine Partners with Leading Government Affairs Firm to Advance Psychedelic Therapeutics - Nasdaq

Jun 12, 2025

Jun 12, 2025

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic ... - Bluefield Daily Telegraph

Jun 12, 2025